Heart failure does not happen suddenly; it progresses slowly. The body starts giving its indications in advance. These signs ...

Heart attacks increase heart failure risk. Dr. Teuteberg believes cardiac attacks damage the heart, making it pump less ...

It is not uncommon for those suffering from heart failure to also experience a variety of symptoms, and among them is edema, ...

For instance, a recent study found that semaglutide — the active ingredient in Ozempic and Wegovy — may help reduce symptoms of heart failure with preserved ejection fraction (HFpEF) in people ...

Heart failure not only leads to issues in the heart but other organs in the body as well. This can lead to many different symptoms developing, which may need multiple medicines to manage.

Now, new research presented May 11–14 at Heart Failure 2024, a scientific congress of the European Society of Cardiology (ESC), reports that semaglutide reduces the need for and dose of loop ...

A tiny implantable heart device is changing lives for patients with HFpEF heart failure. Scripps La Jolla is among 65 ...

Additionally, N-terminal pro-B-type natriuretic peptide levels were higher in those with heart failure with reduced ejection fraction (3,437.7 pg/mL) versus both HFmrEF and HFpEF (2,171.2 and 977. ...

Heart attacks remain a leading cause of death and disability worldwide. The permanent loss of heart muscle cells—known as ...

About 6.7 million adults in the U.S. currently have heart failure — with nearly one in four Americans expected to develop ...

A team at Florida International University is using digital stethoscopes and machine learning to analyze heartbeats, similar ...

Tirzepatide showed a 38% reduction in the risk of heart failure outcomes, assessed as a composite endpoint, compared to placebo. Risk of hospitalization for heart failure was reduced by 56%.